Current position:Home >Product >
2H-Indol-2-one, 3-cycloheptyl-1,3-dihydro-3-(4-hydroxyphenyl)-6-methoxy-7-methyl-, (3S)-
2H-Indol-2-one, 3-cycloheptyl-1,3-dihydro-3-(4-hydroxyphenyl)-6-methoxy-7-methyl-, (3S)-(1247028-61-0)
- Name: 2H-Indol-2-one, 3-cycloheptyl-1,3-dihydro-3-(4-hydroxyphenyl)-6-methoxy-7-methyl-, (3S)-
- Synonyms:2H-Indol-2-one,3-cycloheptyl-1,3-dihydro-3-(4-hydroxyphenyl)-6-methoxy-7-methyl-,(3S);
- Molecular Formula:C23H27NO3
- Molecular Weight:365.472
- CAS Registry Number:1247028-61-0
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.1247028-61-0 2H-Indol-2-one, 3-cycloheptyl-1,3-dihydro-3-(4-hydroxyphenyl)-6-methoxy-7-methyl-, (3S)-
Assay:99% Package:According client's requirements Transportation:by sea/by air/by courier Application:Chemical products
Min. Order:1Kilogram
Supplier:Hangzhou ZeErRui Chemical Co., Ltd. [
China (Mainland)] CAS No.1247028-61-0 2H-Indol-2-one, 3-cycloheptyl-1,3-dihydro-3-(4-hydroxyphenyl)-6-methoxy-7-methyl-, (3S)-
Assay:99% Appearance:White fine powder Package:according to the clients requirement Transportation:Transportation by express, air, sea; port mainly to Qingdao / Tianjin / Shanghai, or according to customer needs to send different ports and aviation. Application:An important raw material and intermed
Min. Order:1Kilogram
Supplier:Shandong Hanjiang Chemical Co., Ltd. [
China (Mainland)] CAS No.1247028-61-0 2H-Indol-2-one, 3-cycloheptyl-1,3-dihydro-3-(4-hydroxyphenyl)-6-methoxy-7-methyl-, (3S)-
Assay:99% Application:api
Min. Order:0
Supplier:Zibo Hangyu Biotechnology Development Co., Ltd [
China (Mainland)]
Other Product
- 924270-31-5/MK-1220
- 414910-27-3/casopitant
- 957194-38-6/Methanone, [4-[1-[(2,5-difluorophenyl)methyl]-1,2,3,4-tetrahydropyrido[2,3-b]pyrazin-7-yl]phenyl][(2S)-2-(1-pyrrolidinylmethyl)-1-pyrrolidinyl]-
- 1022957-12-5/Bicyclo[2.2.1]hept-5-ene-2-carboxamide, 3-[[5-chloro-2-[(1-ethyl-2,3,4,5-tetrahydro-6-methoxy-2-oxo-1H-1-benzazepin-7-yl)amino]-4-pyrimidinyl]amino]-, (1S,2S,3R,4R)-
- 1076225-27-8/4-((1R,2R)-2-Hydroxycyclohexyl)-2(trifluoromethyl)benzonitrile
- 166095-95-0/2H-1-Benzopyran-6-carbonitrile, 4-[(4-chlorophenyl)(1H-imidazol-2-ylmethyl)amino]-3,4-dihydro-3-hydroxy-2,2-dimethyl-, monohydrochloride, (3R,4S)- (9CI)
- 481047-50-1/Escitalopram hydrobromide
- 163521-08-2/5-[4-[4-(5-Cyanoindol-3-yl)butyl]piperazin-1-yl]benzofuran-2-carboxamide hydrochloride
- 940907-93-7/Benzonitrile, 2-[[2-[(3R)-3-amino-1-piperidinyl]-4-oxo-3(4H)-quinazolinyl]methyl]-
- 241479-67-4/Isavuconazole
- 103166-95-6/4-Piperidinecarboxylic acid, 1-(3-cyano-3,3-diphenylpropyl)-4-phenyl-, methyl ester
- 116314-66-0/2-Propenamide, 2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-dimethyl-
- 135017-30-0/Propanedinitrile, 2-[1-[2-[[[5-(1-piperidinylmethyl)-2-furanyl]methyl]amino]ethyl]-2-imidazolidinylidene]-
- 1100749-38-9/1,3-Benzenedicarbonitrile, 5-[[1,4-diethyl-2-(2-hydroxyethyl)-1H-imidazol-5-yl]oxy]-
- 862541-45-5/PF 610355
- 652990-07-3/Milveterol
- 804518-03-4/Milveterol hydrochloride
- 503068-34-6/Vilanterol
- 623152-17-0/BMS 582949
- 1247028-61-0/2H-Indol-2-one, 3-cycloheptyl-1,3-dihydro-3-(4-hydroxyphenyl)-6-methoxy-7-methyl-, (3S)-
- 1064684-44-1/Sofosbuvir
- 260270-37-9/6,9-Imino-5H-cyclohepta[c]pyridine, 6,7,8,9-tetrahydro-, (6R,9S)-
- 934995-87-6/MK-0952
- 934995-88-7/Cyclopropanecarboxylic acid, 2-[3'-[3-[(cyclopropylamino)carbonyl]-4-oxo-1,8-naphthyridin-1(4H)-yl]-3-fluoro[1,1'-biphenyl]-4-yl]-, sodium salt (1:1), (1R,2R)-
- 346629-30-9/6-(1-METHANESULFONYL-1-METHYL-ETHYL)-8-(3-[(E)-2-(4-METHANESULFONYL-PHENYL)-2-(3-METHYL-[1,2,4]OXADIAZOL-5-YL)-VINYL]-PHENYL)-QUINOLINE
- 778625-65-3/MK-0489
- 870615-40-0/6H-[1,2,4]Triazolo[4,3-a][1,5]benzodiazepine-6-acetamide, 4,5-dihydro-4-(1H-indol-3-ylmethyl)-N-(1-methylethyl)-5-oxo-1-phenyl-N-(phenylmethyl)-, (-)-
- 870615-43-3/6H-[1,2,4]Triazolo[4,3-a][1,5]benzodiazepine-6-acetamide, 4,5-dihydro-4-(1H-indol-3-ylmethyl)-N-(1-methylethyl)-5-oxo-1-phenyl-N-(phenylmethyl)-
- 305366-98-7/GI 181771
- 221671-61-0/SR 146131